Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced it will present data from the Phase 1 dose ...

After decades of partnership with the U.S. government, American colleges are facing new doubts about the future of their ...

As one of the regions most affected by the global climate crisis, local scientists are struggling with canceled research ...

A publication called Slay News promoted this rumor in three similar articles in 2024 and 2025, all without providing ...

Detailed price information for Medicenna Therapeutics Corp (MDNA-T) from The Globe and Mail including charting and trades.

Trump’s nominee to lead the Centers for Medicare and Medicaid Services is entangled in another potential conflict of interest ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Background The transition to higher education represents a demanding adaptation process with several socioeconomic factors involved. Mental health problems among university students have been ...

There’s a whole lot of false consciousness running around. How to battle against it?  It’s a matter of public health.  It’s as bad as the measles.  The Wobblies, or members of the IWW (Industrial ...

A unique opportunity to work on a very interesting AI challenge aimed at deciphering the human genome, giving us better understanding and insights into diseases and their causes. You will be guided by ...

Much like construction happening with the legislative offices, gutting and stuffing began in earnest today — the 35th day of the legislative ...